In Vivo Testing from a CRO Perspective-Challenges and Changes | Paula Niksa, Director of Operations, Site Lead, Charles River Virus Hunting the NGS Way - The Magic, The Mystery, The Myths (Debunked)… | Colette Côté, PhD, Chief Portfolio Officer and General Manager, US, Pathoquest Impac...
"This draft guidance is aligned with the FDA's broader commitment to helping facilitate the development of high-quality, safe, and effective medical devices," saidMichelle Tarver, M.D., Ph.D., director of the FDA's Center for Devices and Radiological Health. ...
Williams, Ph.D. Unlocking the Next Quantum Leap in Precision Medicine – A Town Hall Discussion (CME Eligible) Co-Chairs Amanda Paulovich, Professor, Aven Foundation Endowed Chair Fred Hutchinson Cancer Center Susan Monarezm Deputy Director ARPA-H Henry Rodriguez, NCI/NIH Eric Schadt, Pathos ...
Conference co-chairs include Derek Johnson (Managing Director and General Counsel, Portal Innovations) and Lulu Wang (Head of IP, Orna Therapeutics). Hyman, Phelps & McNamara, P.C.’sCharles Raverwill speak during a panel discussion, titled “Preparing to Launch Preparing to Launch: Designing Yo...
“I think the general take-home message is: Don’t view these ODACs as an indictment against immunotherapy. It is not. It’s, rather, an opportunity for us to reset our expectations about it,” he said. Balar said he does not expect any more immunotherapy accelerated approvals ...
Williams, Ph.D. Unlocking the Next Quantum Leap in Precision Medicine – A Town Hall Discussion (CME Eligible) Co-Chairs Amanda Paulovich, Professor, Aven Foundation Endowed Chair Fred Hutchinson Cancer Center Susan Monarezm Deputy Director ARPA-H Henry Rodriguez, NCI/NIH Eric Schadt, Pathos ...
2005letterfrom then FDA Commissioner Lester Crawford to California Attorney General Bill Lockyer, and a March 21, 2007 letter from Terry C. Troxell, Ph.D., Director, Office of Plant and Dairy Foods, Center for Food Safety and Applied Nutrition, to Joan Denton, Director, California Office of...
Martin Mackay, Ph.D., now the co-founder of Connecticut biotech RallyBio who formerly guided the R&D efforts at Pfizer, remembers being ridiculed in 2010 when he told Bloomberg Television that the company—which was in a minor lull at the time—and the industry in general were i...
Theresa Werner, MD, deputy director of Huntsman Cancer Institute and a professor of oncology at the University of Utah (the U), and Crystal Lumpkins, Ph.D., MA, investigator at Huntsman Cancer Institute and associate professor at the U, discuss some things you need to know. ...
carcinogenic compounds in food-producing animals if certain conditions were met. "The FDA felt that food-producing animals could be exposed to carcinogenic drugs and not necessarily pass cancer-causing chemicals on to humans,"Woodrow Knight, Ph.D., director of the CVM's Division of Production ...